The store will not work correctly when cookies are disabled.
2,3-Dichloro-N-(3-hydroxy-1H-pyrazolo[3,4-d]pyrimidin-4-yl)benzenesulfonamide
ID: ALA4090166
PubChem CID: 137643503
Max Phase: Preclinical
Molecular Formula: C11H7Cl2N5O3S
Molecular Weight: 360.18
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1ncnc2[nH]nc(O)c12)c1cccc(Cl)c1Cl
Standard InChI: InChI=1S/C11H7Cl2N5O3S/c12-5-2-1-3-6(8(5)13)22(20,21)18-10-7-9(14-4-15-10)16-17-11(7)19/h1-4H,(H3,14,15,16,17,18,19)
Standard InChI Key: PGRGKRXPFYRQPM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
30.7944 -11.7290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2094 -11.0135 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.3824 -11.0119 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9282 -11.4229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2108 -10.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9271 -9.7766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9260 -8.9503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2085 -8.5371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4905 -8.9563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4952 -9.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4147 -12.4088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4108 -13.7474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8994 -13.0800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6251 -13.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6314 -12.6655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9227 -12.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2072 -12.6570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2049 -13.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9142 -13.8950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6427 -10.1913 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
32.6418 -8.5358 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.6704 -11.6222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 15 1 0
14 12 1 0
12 13 1 0
13 11 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
16 4 1 0
6 20 1 0
7 21 1 0
11 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.18 | Molecular Weight (Monoisotopic): 358.9647 | AlogP: 2.17 | #Rotatable Bonds: 3 |
Polar Surface Area: 120.86 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.47 | CX Basic pKa: 0.70 | CX LogP: 2.32 | CX LogD: -0.32 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.66 | Np Likeness Score: -1.84 |
References
1. Miah AH, Champigny AC, Graves RH, Hodgson ST, Percy JM, Procopiou PA.. (2017) Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists., 25 (20): [PMID:28801066] [10.1016/j.bmc.2017.07.052] |